MedTrace Logo

Incisive CT Clinica Trial Protocol

NCT05020262 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2021-08-25

No results posted yet for this study

Summary

The purpose of this study was to evaluate whether the new features of Incisive CT: Precise Image, (PI) and Precise Cardiac (PC) had the expected effectiveness

Conditions

  • CT Images

Interventions

OTHER

CT Image reconstruction

Retrospectively collects CT Images and reconstruct using PI/PC and Idose4/Cardiac Images to assessment the performance of the two new software functions of Incisive CT. No direct intervention to patients. And ICF is exempted by EC.

Sponsors & Collaborators

  • The Second Hospital of Nanjing Medical University

    collaborator OTHER

  • Philips Healthcare (Suzhou) Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chao Du, Deputy Director · The Second Hospital of Nanjing Medical University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2021-10-31
Completion
2022-01-31
FDA Drug
Yes
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05020262 on ClinicalTrials.gov